236 related articles for article (PubMed ID: 9687159)
1. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
2. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.
McClure N; Healy DL; Rogers PA; Sullivan J; Beaton L; Haning RV; Connolly DT; Robertson DM
Lancet; 1994 Jul; 344(8917):235-6. PubMed ID: 7913160
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
7. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
8. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.
Levin ER; Rosen GF; Cassidenti DL; Yee B; Meldrum D; Wisot A; Pedram A
J Clin Invest; 1998 Dec; 102(11):1978-85. PubMed ID: 9835623
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.
Delvigne A; Rozenberg S
Int J Fertil Womens Med; 2002; 47(5):211-26. PubMed ID: 12469708
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls.
Enskog A; Nilsson L; Brännström M
Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):196-201. PubMed ID: 11384807
[TBL] [Abstract][Full Text] [Related]
11. Ovarian hyperstimulation syndrome-model rats; the manifestation and clinical implication.
Ohba T; Ujioka T; Ishikawa K; Tanaka N; Okamura H
Mol Cell Endocrinol; 2003 Apr; 202(1-2):47-52. PubMed ID: 12770729
[TBL] [Abstract][Full Text] [Related]
12. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
Abramov Y; Barak V; Nisman B; Schenker JG
Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
D'Ambrogio G; Fasciani A; Monti M; Cattani R; Genazzani AR; Artini PG
Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
[TBL] [Abstract][Full Text] [Related]
16. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
Gómez R; Simón C; Remohí J; Pellicer A
Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Ruiz A; Pellicer A; Garcia-Velasco JA
J Clin Endocrinol Metab; 2007 Jan; 92(1):314-21. PubMed ID: 17032719
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas.
Elchalal U; Schenker JG
Hum Reprod; 1997 Jun; 12(6):1129-37. PubMed ID: 9221989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
